State Health Services Organisation

The medical center is at the forefront of research in Opioid Use Disorder treatment, focusing on innovative approaches to enhance patient outcomes. By exploring the efficacy of novel therapies, the center aims to improve the quality of life for individuals struggling with opioid addiction.

• Biomarker Identification
• Complementary Therapies
• Relapse Prevention

Through its cutting-edge research, the center is dedicated to identifying biomarkers that predict relapse vulnerability, thereby enabling personalized treatment plans that are more effective in maintaining long-term abstinence.

Specializing in the development of advanced pharmacotherapies, the center is committed to integrating new treatments with existing protocols to enhance their effectiveness. This approach is particularly focused on reducing cravings and preventing relapse in patients with opioid-use disorders.

• Ketamine as a Treatment Option
• Integration with Existing Therapies
• Prolonging Abstinence

The center's research into the use of ketamine as a complementary treatment is paving the way for new therapeutic strategies that could significantly improve patient adherence and recovery rates.